Veterinary Diagnostics Market Analysis: Key Players, Emerging Technolo…
페이지 정보
본문
Veterinary Diagnostics Market to Accelerate as Preventive Animal Healthcare and Advanced Testing Technologies Expand
Market Estimation, Growth Drivers, and Opportunities
The global Veterinary Diagnostics Market was valued at USD 9.72 billion in 2025 and is projected to reach USD 23.99 billion by 2034, growing at a compound annual growth rate (CAGR) of 10.56% from 2026 to 2034. The market is benefiting from increasing pet ownership, rising expenditure on animal healthcare, greater awareness of zoonotic diseases, and the growing need to monitor livestock health.
Veterinary diagnostics plays a critical role in identifying infectious diseases, metabolic disorders, hereditary conditions, and other health problems in companion animals and livestock. Rising demand for preventive veterinary care is encouraging clinics and laboratories to adopt advanced testing solutions that support earlier diagnosis and treatment decisions. The expansion of commercial livestock production and the need to protect food safety are also creating demand for reliable disease detection and surveillance.
Technological innovation is opening further opportunities through molecular diagnostics, automated analyzers, rapid point-of-care testing, and artificial intelligence-enabled interpretation. Portable testing systems can improve access to diagnostics in veterinary clinics and remote agricultural settings, while cloud-connected platforms can help practitioners manage results more efficiently. Companies that combine accuracy, speed, affordability, and easy-to-use testing systems are well positioned to benefit from the market’s expansion.
* Request Your Free Sample Copy: https://www.maximizemarketresearch.com/request-sample/34589/
U.S. Market Trends and Investment in 2025
The United States continued to be an important center for veterinary diagnostic innovation in 2025, supported by advanced laboratory infrastructure, companion-animal healthcare spending, and government-backed disease surveillance. In January 2025, IDEXX Laboratories announced IDEXX Cancer Dx, a blood-based diagnostic panel initially designed to help detect lymphoma in dogs, with North American availability beginning in March. The test reflects growing interest in early cancer detection and the integration of diagnostic screening into routine veterinary care. Government investment also supported animal disease preparedness. According to the U.S. Department of Agriculture’s October 2025 National Animal Health Laboratory Network briefing, total FY2025 network funding reached approximately USD 43.16 million in allocated funding, including additional support for avian-health testing and emerging dairy-cattle disease investigations. These developments reinforce demand for laboratory capacity, rapid testing, and innovative diagnostic tools.
Market Segmentation: Leading Categories
According to the market report, immunoassays dominated the market by testing type in 2025. These tests are widely used to detect infectious diseases, hormones, and metabolic conditions. Their relatively rapid results, established clinical applications, and suitability for both laboratory and point-of-care settings support their adoption.
By end use, laboratories held the largest share, at approximately 49% in 2025. Veterinary laboratories support disease surveillance, confirmatory testing, research, quality assurance, and monitoring programs. Their role in identifying and tracking transboundary animal diseases makes them essential to veterinary healthcare systems.
Regionally, North America led the global market in 2025, benefiting from developed veterinary infrastructure, high levels of pet ownership, research investment, and established disease-monitoring programs.
Key Players
North America
1. IDEXX Laboratories Inc. (USA)
2. Zoetis Services LLC (USA)
3. Heska Corporation (USA)
4. Thermo Fisher Scientific, Inc. (USA)
5. Antech Diagnostics Inc. (Mars, Inc.) (USA)
6. VCA Animal Hospitals (Mars, Inc.) (USA)
7. Neogen Corporation (USA)
Europe
8. bioMérieux SA (France)
9. Virbac Corp (France)
10. Alvedia (France)
11. Randox Laboratories Ltd. (UK)
12. Biopanda Reagents (UK)
13. INDICAL BIOSCIENCE GmbH (Germany)
14. Fassisi GmbH (Germany)
15. QIAGEN N.V. (Germany)
16. Agrolabo S.p.A. (Italy)
Asia-Pacific
17. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
18. Shenzhen Bioeasy Biotechnology Co. Ltd. (China)
19. BioNote Inc. (South Korea)
20. FUJIFILM Holdings Corporation (Japan)
21. IM3Vet Pty Ltd. (Australia)
Competitive Analysis: Major Companies and Innovation
The market report identifies IDEXX Laboratories, Zoetis, Heska, Thermo Fisher Scientific, and Antech Diagnostics among the major companies operating in the veterinary diagnostics landscape. The available report summary does not establish a verified market-share ranking for these five companies.
- IDEXX Laboratories, Inc. develops diagnostic instruments, laboratory services, and testing solutions for companion animals. Its 2025 Cancer Dx launch demonstrates the opportunity in earlier disease detection and preventive screening.
- Zoetis Inc. combines animal-health products with diagnostic capabilities. Its investment in veterinary healthcare and disease management positions it to serve companion-animal and livestock markets.
- Heska Corporation, now part of Mars Petcare, has a portfolio focused on veterinary diagnostic instruments, laboratory services, and point-of-care testing. Broader distribution and integration within veterinary care networks can support adoption.
- Thermo Fisher Scientific Inc. provides laboratory instruments, reagents, and molecular-testing technologies that can support veterinary disease research and diagnostic workflows.
- Antech Diagnostics, part of Mars Petcare, offers reference laboratory testing and diagnostic services. Its laboratory network and integration with veterinary practices support access to a broad range of tests.
Competition is increasingly shaped by diagnostic accuracy, turnaround time, test-menu breadth, automation, and the ability to integrate results into veterinary practice workflows.
Regional Analysis: Key Countries
United States: Advanced laboratories, pet healthcare expenditure, and USDA-supported disease surveillance underpin market growth. Early cancer detection and rapid infectious-disease testing create opportunities.
United Kingdom: Established veterinary services and animal disease surveillance support diagnostic demand. Continued focus on animal welfare, food safety, and infectious-disease monitoring encourages testing adoption.
Germany: Strong veterinary healthcare infrastructure and livestock production support demand for reliable diagnostics, particularly for infectious-disease monitoring and herd health management.
France: Veterinary research, livestock health requirements, and established animal healthcare services create opportunities for diagnostic laboratories and rapid testing technologies.
Japan: An aging pet population and demand for advanced companion-animal healthcare support the use of laboratory testing and diagnostic instruments.
China: Large livestock populations, expanding companion-animal care, and greater emphasis on food safety and animal disease control provide long-term growth opportunities.
Related Reports:
Global Ductless Fume Hoods Market https://www.maximizemarketresearch.com/market-report/global-ductless-fume-hoods-market/92036/
Veterinary Dental Equipment Market https://www.maximizemarketresearch.com/market-report/veterinary-dental-equipment-market/249639/
Phytoestrogen Supplements Market https://www.maximizemarketresearch.com/market-report/phytoestrogen-supplements-market/259141/
Conclusion
The Veterinary Diagnostics Market is expected to expand as preventive animal healthcare, livestock disease monitoring, and diagnostic innovation gain importance. Immunoassays and laboratory services currently provide important market foundations, while molecular testing, point-of-care systems, and AI-enabled platforms offer further opportunities. Companies that improve testing speed, accuracy, accessibility, and affordability can strengthen their competitive position. Continued investment in laboratory infrastructure, disease surveillance, and early detection will be crucial to sustaining market growth and improving animal health outcomes.
About Maximize Market Research
Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting firm known for delivering accurate, actionable, and data-driven insights. Our expertise spans diverse industries — including medical devices, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. We provide services such as market-validated forecasts, competitive intelligence, strategic consulting, and industry impact analysis, helping businesses navigate market complexities and achieve sustainable growth.
Contact Maximize Market Research
MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Naval IT Park Phase 3,
Pune-Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India.
????
+91 9607365656
???? [email protected]
댓글목록
no comments.